C. Dustin Waters

623 total citations
22 papers, 467 citations indexed

About

C. Dustin Waters is a scholar working on Epidemiology, Pulmonary and Respiratory Medicine and Pharmacology. According to data from OpenAlex, C. Dustin Waters has authored 22 papers receiving a total of 467 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Epidemiology, 8 papers in Pulmonary and Respiratory Medicine and 7 papers in Pharmacology. Recurrent topics in C. Dustin Waters's work include Pneumonia and Respiratory Infections (9 papers), Antibiotics Pharmacokinetics and Efficacy (6 papers) and Cystic Fibrosis Research Advances (6 papers). C. Dustin Waters is often cited by papers focused on Pneumonia and Respiratory Infections (9 papers), Antibiotics Pharmacokinetics and Efficacy (6 papers) and Cystic Fibrosis Research Advances (6 papers). C. Dustin Waters collaborates with scholars based in United States and Australia. C. Dustin Waters's co-authors include David C. Young, Krow Ampofo, Jeffery T. Zobell, Michael G. Spigarelli, Catherine M.T. Sherwin, Chris Stockmann, Duane R. Hospenthal, Susan E. Beekmann, Philip M. Polgreen and Jared Olson and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of the American Society of Nephrology and Physical Therapy.

In The Last Decade

C. Dustin Waters

18 papers receiving 458 citations

Peers

Countries citing papers authored by C. Dustin Waters

Since Specialization

Citations

This map shows the geographic impact of C. Dustin Waters's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Dustin Waters with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Dustin Waters more than expected).

Fields of papers citing papers by C. Dustin Waters

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Dustin Waters. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Dustin Waters. The network helps show where C. Dustin Waters may publish in the future.

Co-authorship network of co-authors of C. Dustin Waters

This figure shows the co-authorship network connecting the top 25 collaborators of C. Dustin Waters. A scholar is included among the top collaborators of C. Dustin Waters based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Dustin Waters. C. Dustin Waters is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Interventions to optimize duration of antibiotic therapy and encourage oral transition for uncomplicated gram-negative blood stream infections across a health system 2025 ·Infection Control and Hospital Epidemiology ·Jared Olson, Adam L. Hersh, (unknown), C. Dustin Waters, Brandon Webb, (unknown), (unknown), (unknown), Nora F. Fino, Rachel Foster, (unknown), Erin D. Stahl, James B. Rhodes, Edward Stenehjem, Andrew T. Pavia, Payal Patel, Allan Seibert, Whitney R. Buckel	0
2	Penicillin allergy labels are associated with a greater number of courses of antibiotics after hospitalization 2025 ·Allergy and Asthma Proceedings ·C. Dustin Waters, (unknown), (unknown)	0
3	Real-World Effectiveness of Intravenous and Oral Antibiotic Stepdown Strategies for Gram-Negative Complicated Urinary Tract Infection With Bacteremia 2024 ·Open Forum Infectious Diseases ·(unknown), (unknown), (unknown), Jared Olson, Allison Butler, C. Dustin Waters, (unknown), (unknown), Brandon Webb	3
4	True Hyponatremia Secondary to Intravenous Immunoglobulin Infusion 2024 ·Journal of the American Society of Nephrology ·(unknown), C. Dustin Waters, Siddhartha Kattamanchi, (unknown)	0
5	Outcomes of patients with bacteriuria/pyuria of clinically undetermined significance (BPCUS) treated with antibiotics in 23 community hospital emergency departments 2023 ·SHILAP Revista de lepidopterología ·(unknown), C. Dustin Waters, Jared Olson, (unknown), (unknown), (unknown), (unknown), (unknown), Rachel Foster, (unknown), Todd J. Vento	0
6	Effect of tele‐COVID rounds and a tele‐stewardship intervention on antibiotic use in COVID‐19 patients admitted to 17 small community hospitals 2023 ·Journal of Hospital Medicine ·(unknown), (unknown), Brandon Webb, Edward Stenehjem, (unknown), (unknown), (unknown), (unknown), C. Dustin Waters, Nancy Grisel, Todd J. Vento	2
7	Oral β-Lactams, Fluoroquinolones, or Trimethoprim-Sulfamethoxazole for Definitive Treatment of Uncomplicated Escherichia coli or Klebsiella Species Bacteremia From a Urinary Tract Source 2023 ·Open Forum Infectious Diseases ·(unknown), (unknown), (unknown), Jared Olson, (unknown), C. Dustin Waters, Allison Butler, (unknown), Whitney R. Buckel, Brandon Webb	4
8	Impact of a Multifaceted Intervention on Antibiotic Prescribing for Cystitis and Asymptomatic Bacteriuria in 23 Community Hospital Emergency Departments 2023 ·Hospital Pharmacy ·(unknown), (unknown), Jared Olson, (unknown), C. Dustin Waters, (unknown), (unknown), (unknown), (unknown), G Fontaine, Rachel Foster, (unknown), (unknown), Whitney R. Buckel, Todd J. Vento	3
9	Antibiotic prescribing for adult bacteriuria and pyuria in community hospital emergency departments 2020 ·The American Journal of Emergency Medicine ·(unknown), C. Dustin Waters, (unknown), Lisa A. Hoopes, (unknown), (unknown), (unknown), Jared Olson, Todd J. Vento	5
10	Practice Patterns of Infectious Diseases Physicians in Transitioning From Intravenous to Oral Therapy in Patients With Bacteremia 2019 ·Open Forum Infectious Diseases ·Duane R. Hospenthal, C. Dustin Waters, Susan E. Beekmann, Philip M. Polgreen	30
11	Rate of positive cultures necessitating definitive treatment in patients receiving empiric vancomycin therapy 2018 ·Infection Control and Hospital Epidemiology ·C. Dustin Waters, (unknown)	4
12	Pharmacist-driven antimicrobial stewardship program in an institution without infectious diseases physician support 2015 ·American Journal of Health-System Pharmacy ·C. Dustin Waters	46
13	Optimization of anti‐pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: VI. Executive summary 2013 ·Pediatric Pulmonology ·Jeffery T. Zobell, David C. Young, C. Dustin Waters, Krow Ampofo, Chris Stockmann, Catherine M.T. Sherwin, Michael G. Spigarelli	24
14	Optimization of anti‐pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: V. Aminoglycosides 2013 ·Pediatric Pulmonology ·David C. Young, Jeffery T. Zobell, Chris Stockmann, C. Dustin Waters, Krow Ampofo, Catherine M.T. Sherwin, Michael G. Spigarelli	48
15	Optimization of anti‐pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: II. cephalosporins and penicillins 2012 ·Pediatric Pulmonology ·Jeffery T. Zobell, C. Dustin Waters, David C. Young, Chris Stockmann, Krow Ampofo, Catherine M.T. Sherwin, Michael G. Spigarelli	48
16	Optimization of anti‐pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: I. aztreonam and carbapenems 2012 ·Pediatric Pulmonology ·Jeffery T. Zobell, David C. Young, C. Dustin Waters, Chris Stockmann, Krow Ampofo, Catherine M.T. Sherwin, Michael G. Spigarelli	53
17	Optimization of anti‐pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: IV. colistimethate sodium 2012 ·Pediatric Pulmonology ·David C. Young, Jeffery T. Zobell, C. Dustin Waters, Krow Ampofo, Chris Stockmann, Catherine M.T. Sherwin, Michael G. Spigarelli	13
18	Optimization of anti‐pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: III. fluoroquinolones 2012 ·Pediatric Pulmonology ·Chris Stockmann, Catherine M.T. Sherwin, Jeffery T. Zobell, David C. Young, C. Dustin Waters, Michael G. Spigarelli, Krow Ampofo	31
19	Move to Improve: The Feasibility of Using an Early Mobility Protocol to Increase Ambulation in the Intensive and Intermediate Care Settings 2012 ·Physical Therapy ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), C. Dustin Waters, (unknown)	88
20	A survey of the utilization of anti‐pseudomonal beta‐lactam therapy in cystic fibrosis patients 2011 ·Pediatric Pulmonology ·Jeffery T. Zobell, David C. Young, C. Dustin Waters, Krow Ampofo, Jared Cash, Bruce C. Marshall, Jared Olson, Barbara A. Chatfield	38

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact